Impact of Early Antiretroviral Treatment on Tissue-Resident Memory CD4+ T Cells in the Gastrointestinal Tract
The Journal of Infectious Diseases · 16.11.2026 · 234 (5) · e1157-e1169
DOI: 10.1093/infdis/jiag358 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 16.07.2026. Verfasst von Sinmanus Vimonpatranon und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Retrovirology, Walter Reed Army Institute of Research-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand. Hauptthemen laut MEDLINE: HIV Infections, CD4-Positive T-Lymphocytes, Anti-Retroviral Agents, Immunologic Memory. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Henry M. Jackson Foundation, Advancement of Military Medicine, US Department of Defense.
Abstract (Originalsprache)
Background
Tissue-resident memory CD4+ T (CD4+ TRM) cells are long-lived, seldom-circulating cells that reside for long periods in most tissues. TRM cells can mount rapid, antigen-specific responses to pathogens and contribute to mucosal barrier homeostasis by regulating commensal interactions. At the intestinal mucosa, the main site of early human immunodeficiency virus (HIV) replication, CD4+ TRM cells may serve as virus targets; however, limited data are available regarding their dynamics during acute HIV-1 infection and antiretroviral treatment.
Methods
This was a nested cross-sectional study within a longitudinal cohort.
Results
Sigmoid CD4+ TRM (CD69+CD103+) cells had a higher expression of CCR5 than CD4+ non-TRM (CD69−CD103−) cells, suggestive of increased susceptibility to HIV-1 infection. Consistent with this, sigmoid CD4+ TRM but not CD4+ non-TRM cells were depleted/nonreplenished despite long-term ART, regardless of the Fiebig stage at which treatment was initiated during acute HIV infection. In contrast, overall sigmoid CD4+ T cells were comparable in abundance with people living without HIV if treatment was initiated at Fiebig stage I or II, but they were significantly decreased if treatment was initiated at Fiebig stage III or beyond, suggesting preferential early depletion/nonreplenishment of CD4+ TRM cells. The loss/nonreplenishment of sigmoid CD4+ TRM cells was associated with a lower abundance of that short-chain fatty acid–producing commensal bacteria that are crucial for the maintenance of mucosal homeostasis, a higher abundance of opportunistic pathobionts Desulfovibrio, and increased soluble biomarkers of systemic inflammation that drive non-AIDS mortality.
Conclusions
Sigmoid CD4+ TRM cells may be early mucosal targets of HIV-1 infection and that their persistent depletion contributes to decreased mucosal barrier function, warranting development of therapeutic strategies that can restore CD4+ TRM cells during HIV treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Retrovirology, Walter Reed Army Institute of Research-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
- Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
- Department of Medicine, Faculty of Medicine, Chulalongkorn Hospital, Bangkok, Thailand.
- US Military HIV Research Program, Center for Infectious Disease Research, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
- Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
- SEARCH Research Foundation, Bangkok, Thailand.
ORCID-Profile: Sinmanus Vimonpatranon, Aloysious Ssemaganda, Yuwadee Phuang-Ngern, Chayada Sajjaweerawan, Shruti Rathore, Rasmi Thomas, Suteeraporn Pinyakorn, Sandhya Vasan, Nittaya Phanuphak, Lyle R McKinnon
Förderung
- Henry M. Jackson Foundation
- Advancement of Military Medicine
- US Department of Defense
- Thai Red Cross AIDS Research Centre
- Government Pharmaceutical Organization
- Gilead
- Merck
- ViiV Healthcare
Zitieren
APA
Vimonpatranon, S., Ssemaganda, A., Phuang-Ngern, Y., Sajjaweerawan, C., Saetun, P., Shakery, T., Sukhumvittaya, S., Rathore, S., Rerknimitr, R., Ehrenberg, P. K., Eiser, D., Ratnaratorn, N., Trautmann, L., Choi, S., Severini, G., Thomas, R., Sacdalan, C., Pinyakorn, S., Ananworanich, J., …, & RV254/SEARCH010 and RV304/SEARCH013 study groups (2026). Impact of Early Antiretroviral Treatment on Tissue-Resident Memory CD4+ T Cells in the Gastrointestinal Tract. The Journal of Infectious Diseases, 234(5), e1157-e1169. https://doi.org/10.1093/infdis/jiag358
Vancouver
Vimonpatranon S, Ssemaganda A, Phuang-Ngern Y, Sajjaweerawan C, Saetun P, Shakery T, et al. Impact of Early Antiretroviral Treatment on Tissue-Resident Memory CD4+ T Cells in the Gastrointestinal Tract. The Journal of Infectious Diseases. 2026;234(5):e1157-e1169. doi:10.1093/infdis/jiag358
BibTeX
@article{Vimonpatranon2026,
author = {Vimonpatranon, Sinmanus and Ssemaganda, Aloysious and Phuang-Ngern, Yuwadee and Sajjaweerawan, Chayada and Saetun, Putita and Shakery, Termeh and Sukhumvittaya, Suchada and Rathore, Shruti and Rerknimitr, Rungsun and Ehrenberg, Phillip K and Eiser, Daina and Ratnaratorn, Nisakorn and Trautmann, Lydie and Choi, Sandra and Severini, Giulia and Thomas, Rasmi and Sacdalan, Carlo and Pinyakorn, Suteeraporn and Ananworanich, Jintanat and Cowden, Jessica and Hsu, Denise and Vasan, Sandhya and Phanuphak, Nittaya and McKinnon, Lyle R and Schuetz, Alexandra and RV254/SEARCH010 and RV304/SEARCH013 study groups, RV254/SEARCH010 and RV304/SEARCH013 study groups},
title = {Impact of Early Antiretroviral Treatment on Tissue-Resident Memory CD4+ T Cells in the Gastrointestinal Tract},
journal = {The Journal of Infectious Diseases},
year = {2026},
volume = {234},
number = {5},
pages = {e1157--e1169},
doi = {10.1093/infdis/jiag358}
}
EUVIMED